BETAThis is a new independent transparency project, not an official government website. The data is sourced from public registers and may contain errors, so always verify against the official source. If you find a problem, please report it here.
Cefas are seeking to establish a Framework for the provision of Next-Generation Sequencing (NGS) services, for a variety of NGS analyses methods, to support the delivery of numerous and varied research programmes that are utilising genomics.
The framework is split into 4 Lots and Suppliers can bid for any number of Lots. Cefas intends to award up to 5 Contracts for each Lot, based on Suppliers meeting the required technical and pricing evaluation criteria. Cefas will then call-off from the framework for individual project requirements, as set out in the full Specification of Requirement document in the Bidder Pack. If a Supplier is awarded multiple Lots, one Contract will be awarded to cover the relevant Lots.
The Contract implementation is expected to start in August 2026 for a period of 3 years with the option to extend for 2 further periods of 12 months each.
Prices will be fixed for the initial 3 year period of the Contract. Prices may then be increased on an annual basis if the Contract is extended, in line with CPI.
Full details of the tender and framework processes are set out in the Bidder Pack documents.
PLEASE NOTE: All Suppliers bidding for any number of Lots must complete the Procurement Specific Questionnaire Envelope.
Lot 1 - Targeted Sequencing
Suppliers will deliver targeted sequencing analyses, such as:
Lot 2 - Whole Genome
Suppliers will deliver whole genome, metagenomic and transcriptomic sequencing, in applications such as:
Lot 3 - Long-Read Sequencing
Suppliers will provide long-read sequencing analysis, using either PacBio or Oxford Nanopore Technologies. This may be for several different applications, mainly studies of:
Lot 4 - Ad-Hoc Requirements
Suppliers will ad-hoc requests, i.e. those that do not fit in the prior lot categories. This would most likely be utilised when a unique/proprietary technology or analysis is required, such as RAD-Seq, that Cefas cannot undertake in-house.
Specifics would be detailed in the individual project request via the call-off process, which will be a mini-competition process as set out in Appendix 4.
Framework contract: £1,000,000 total value shared among 10 suppliers. Estimated equal shares shown below.
| Supplier | Identifier | Est. Share | Lots Won | Cross-References |
|---|---|---|---|---|
| Biomarker Technologies (BMK) GmbH | Procurement ID: PTNP-2887-BHHN | ~£100,000 | 1 lot Lot 1 - Targeted Sequencing | - |
| Earlham Institute | Charity Commission: 1136213 | ~£100,000 | 1 lot Lot 1 - Targeted Sequencing | - |
| Edinburgh Genetics Limited | Procurement ID: PYHR-1723-HVMX | ~£100,000 | 1 lot Lot 1 - Targeted Sequencing | - |
| Edinburgh Innovations Limited | Procurement ID: PVTD-5275-VPLL | ~£100,000 | 1 lot Lot 1 - Targeted Sequencing | - |
| Northumbria University | Procurement ID: PCCM-8851-PBTR | ~£100,000 | 1 lot Lot 1 - Targeted Sequencing | - |
| Novogene (UK) Company Limited | Procurement ID: PWPB-6441-HXZL | ~£100,000 | 1 lot Lot 1 - Targeted Sequencing | - |
| QIB Extra Limited | Procurement ID: PCDR-3422-GGMM | ~£100,000 | 1 lot Lot 1 - Targeted Sequencing | - |
| Source BioScience UK Limited | Procurement ID: PDTH-8893-GTCW | ~£100,000 | 1 lot Lot 1 - Targeted Sequencing | - |
| University of Exeter | Procurement ID: PZYG-2396-XCRZ | ~£100,000 | 1 lot Lot 1 - Targeted Sequencing | - |
| University of Plymouth | Procurement ID: PQHL-4825-PGGL | ~£100,000 | 1 lot Lot 1 - Targeted Sequencing | - |
Taken from this notice, not from Companies House. Check the original notice — details change and are not updated here.
This procurement was divided into 5 lots, each awarded separately. 47 bids were received in total.
| Lot | Value | Bids Received | Awarded To | Status |
|---|---|---|---|---|
| Lot 1 Lot 1 - Targeted Sequencing Aug 2026 – Aug 2029 | £250,000 | 13 | University of Plymouth Source BioScience UK Limited Earlham Institute Edinburgh Innovations Limited Novogene (UK) Company Limited QIB Extra Limited Northumbria University University of Exeter Edinburgh Genetics Limited Biomarker Technologies (BMK) GmbH | active |
| Lot 2 Lot 2 - Whole Genome Aug 2026 – Aug 2029 | £250,000 | 12 | - | complete |
| Lot 3 Lot 3 - Long-Read Sequencing Aug 2026 – Aug 2029 | £250,000 | 12 | - | complete |
| Lot 4 Lot 4 - Ad-Hoc Requirements Aug 2026 – Aug 2029 | £250,000 | 10 | - | complete |
| Lot 5 DUMMY LOT - PLEASE IGNORE Aug 2026 – Aug 2029 | £0 | - | - | active |
Weightings from the notice, applied to every lot.